FDA.reportPublic FDA data

Application 203478

Type
ANDA
Sponsor
NATCO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATETABLET, ORALLY DISINTEGRATING;ORALEQ 5MG BASENoNo
002RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATETABLET, ORALLY DISINTEGRATING;ORALEQ 10MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51991-362RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-362RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-362RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-363RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-363RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-363RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateBreckenridge Pharmaceutical, Inc.ANDACurrent
63187-563RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateProficient Rx LPANDACurrent
63187-563RIZATRIPTAN BenzoateRIZATRIPTAN BenzoateProficient Rx LPANDACurrent